Overview

A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
To collect and summarize information on the diagnosis, management, and clinical and mycological outcomes of patients with systemic fungal infections in order to better understand the effectiveness of antifungals in the treatment of Systemic Fungal Infections (SFI) in India.
Details
Lead Sponsor:
Pfizer
Treatments:
Voriconazole